blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3710043

EP3710043 - FGF10 FOR THE TREATMENT OF HEART DISEASES [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  15.03.2024
Database last updated on 30.10.2024
FormerGrant of patent is intended
Status updated on  16.11.2023
FormerExamination is in progress
Status updated on  09.07.2021
FormerRequest for examination was made
Status updated on  21.08.2020
FormerThe international publication has been made
Status updated on  28.05.2019
Formerunknown
Status updated on  27.11.2018
Most recent event   Tooltip11.10.2024Lapse of the patent in a contracting statepublished on 13.11.2024 [2024/46]
Applicant(s)For all designated states
Universite d'Aix-Marseille
Jardin du Pharo
58, boulevard Charles Livon
13007 Marseille / FR
For all designated states
INSERM - Institut National de la Santé et de la Recherche Médicale
101, rue de Tolbiac
75013 Paris / FR
[2020/39]
Inventor(s)01 / ROCHAIS, Francesca, Nadège, Joëlle
584 Allé des Primevères
83330 Le Beausset / FR
 [2020/39]
Representative(s)Cabinet Becker et Associés
25, rue Louis le Grand
75002 Paris / FR
[2020/39]
Application number, filing date18803673.516.11.2018
[2020/39]
WO2018EP81584
Priority number, dateEP2017030659416.11.2017         Original published format: EP 17306594
[2020/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019097001
Date:23.05.2019
Language:EN
[2019/21]
Type: A1 Application with search report 
No.:EP3710043
Date:23.09.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 23.05.2019 takes the place of the publication of the European patent application.
[2020/39]
Type: B1 Patent specification 
No.:EP3710043
Date:17.04.2024
Language:EN
[2024/16]
Search report(s)International search report - published on:EP23.05.2019
ClassificationIPC:A61K38/18, C07K14/50, A61P9/10, A61P9/00
[2020/39]
CPC:
A61K38/18 (EP); A61K38/1825 (US); A61P9/00 (EP);
A61P9/10 (EP); C07K14/50 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/39]  
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:FGF10 ZUR BEHANDLUNG VON HERZERKRANKUNGEN[2020/39]
English:FGF10 FOR THE TREATMENT OF HEART DISEASES[2020/39]
French:FGF10 POUR LE TRAITEMENT DE MALADIES CARDIAQUES[2022/47]
Former [2020/39]FGF10 POUR LE TRAITEMENT DE CARDIOPATHIES
Entry into regional phase08.06.2020National basic fee paid 
08.06.2020Designation fee(s) paid 
08.06.2020Examination fee paid 
Examination procedure08.06.2020Examination requested  [2020/39]
08.06.2020Date on which the examining division has become responsible
09.07.2021Despatch of a communication from the examining division (Time limit: M04)
17.11.2021Reply to a communication from the examining division
12.12.2022Despatch of a communication from the examining division (Time limit: M06)
08.06.2023Reply to a communication from the examining division
17.11.2023Communication of intention to grant the patent
11.03.2024Fee for grant paid
11.03.2024Fee for publishing/printing paid
11.03.2024Receipt of the translation of the claim(s)
Fees paidRenewal fee
20.11.2020Renewal fee patent year 03
12.11.2021Renewal fee patent year 04
31.10.2022Renewal fee patent year 05
23.10.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHR17.04.2024
IS17.08.2024
[2024/46]
Cited inInternational search[A]WO0038518  (ARCH DEV CORP [US]);
 [A]US2007071675  (WU CHENGBIN [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.